GLP Watchdog

ElixaMD vs MEDVi

MEDVi has an open FDA warning letter dated February 20, 2026. ElixaMD has none. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at ElixaMD and $199 at MEDVi.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

ElixaMD / MEDVi

ElixaMD logo

ElixaMD

7.4/10

MEDVi logo

MEDVi

7.7/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$199/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit ElixaMDFull review
Visit MEDViFull review

Neither ElixaMD nor MEDVi pays us. Links to them earn nothing. Scores: ElixaMD 7.4, MEDVi 7.7. How we are paid

What the record shows

  1. 01

    MEDVi has an open FDA warning letter dated February 20, 2026. ElixaMD has none.

  2. 02

    ElixaMD names three pharmacies, all 503A. MEDVi names three pharmacies, all 503A.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at ElixaMD and $199 at MEDVi.

  4. 04

    MEDVi lists all 50 states. ElixaMD publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

ElixaMD

MEDVi

Compounded semaglutide injection

$199/mo

$2,388 a year

$199/mo

$2,388 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None; billed monthly
Refunds
Refunded in full if canceled in the first 72 hours before any service, or on medical disqualification; none for a monthly charge already billed
Full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed
Early-exit fee
None stated
None stated

Read off each seller’s own pages. ElixaMD: October 25, 2026. MEDVi: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for ElixaMD

7.4/10
  • No FDA warning letter on record
  • Publishes no state list
Visit ElixaMD

The case for MEDVi

7.7/10

The record gives MEDVi no edge on this pair.

  • Open FDA warning letter, February 20, 2026
Visit MEDVi

Scores

ElixaMD 7.4 · MEDVi 7.7 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.0A
vs
B
6.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

ElixaMD vs MEDVi: questions

MEDVi has an open FDA warning letter dated February 20, 2026. ElixaMD has none. Letters are matched to a seller by company, domain and address, never by a similar name.
ElixaMD names three pharmacies, all 503A. MEDVi names three pharmacies, all 503A. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Neither, by more than $1 a month. ElixaMD charges $199 a month and MEDVi $199 a month.
ElixaMD states you can cancel at any time; refunds: refunded in full if canceled in the first 72 hours before any service, or on medical disqualification; none for a monthly charge already billed. MEDVi states you can cancel at any time; refunds: full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed.
Neither ElixaMD nor MEDVi pays us. Links to them earn nothing. Scores: ElixaMD 7.4, MEDVi 7.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register